Company profile
Polomar Health Services, Inc.
OTC: PMHS · Healthcare · Medical - Care Facilities
#914 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
28DFH 23DQ 12GM 68SS 45
v0.1 · 65/100 weight · provisional
↑ revenue growth (YoY), 3-yr revenue growth · ↓ return on assets, filing timeliness
Methodology →Revenue TTM
$3.2M
Rev growth YoY (TTM)
+4508.7%
Net income (FY)
-$10.7M
Employees
7
as of 2026-08-24
Market cap
$6.1M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$648.2k$648.2k2025
Net income-$10.7M-$10.7M2025
Operating income-$10.6M-$10.6M2025
Total assets$390.0k$390.0k2025
Liabilities$1.6M$1.6M2025
Equity-$1.2M-$1.2M2025
Revenue trend
FY2023 – FY2025 · USD
FY23
FY24
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Polomar Health Services, Inc.’s revenue?
Polomar Health Services, Inc. booked $648.2k in FY2025 revenue, growing 1002% year over year — faster than 96% of Healthcare companies we track, at a -1650.8% net margin.
Peers · Healthcare
Unicycive Therapeutics, Inc.32DSETO Holdings, Inc.54DLexeo Therapeutics, Inc. Common Stock37DMarizyme, Inc.——BioXcel Therapeutics, Inc.27DComera Life Sciences Holdings, Inc.——Neighbors
Los Angeles →Key facts
CEOTerrence Tierney
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersLos Angeles, CA
ExchangeOTC: PMHS
Employees7
IPO date2009-02-09
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.